JP2024544500A5 - - Google Patents
Info
- Publication number
- JP2024544500A5 JP2024544500A5 JP2024526913A JP2024526913A JP2024544500A5 JP 2024544500 A5 JP2024544500 A5 JP 2024544500A5 JP 2024526913 A JP2024526913 A JP 2024526913A JP 2024526913 A JP2024526913 A JP 2024526913A JP 2024544500 A5 JP2024544500 A5 JP 2024544500A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- patient
- agitation
- treated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163283696P | 2021-11-29 | 2021-11-29 | |
| US63/283,696 | 2021-11-29 | ||
| PCT/US2022/079861 WO2023097151A1 (en) | 2021-11-29 | 2022-11-15 | Methods of treating agitation and other dementia-associated behavioral symptoms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544500A JP2024544500A (ja) | 2024-12-03 |
| JP2024544500A5 true JP2024544500A5 (https=) | 2025-11-26 |
Family
ID=86540411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526913A Pending JP2024544500A (ja) | 2021-11-29 | 2022-11-15 | 焦燥性興奮および他の認知症関連行動症状を治療する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20240423998A1 (https=) |
| EP (1) | EP4440566A4 (https=) |
| JP (1) | JP2024544500A (https=) |
| CN (1) | CN118354769A (https=) |
| CA (1) | CA3236462A1 (https=) |
| MX (1) | MX2024006505A (https=) |
| WO (1) | WO2023097151A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021216139A1 (en) * | 2020-04-23 | 2021-10-28 | Woolsey Pharmaceuticals, Inc | Methods of using rho kinase inhibitors to treat alzheimer's disease |
| WO2025024104A2 (en) * | 2023-07-06 | 2025-01-30 | Woolsey Pharmaceuticals, Inc. | Method for reducing caregiver burden associated with alzheimer's disease |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0104340D0 (sv) * | 2001-12-20 | 2001-12-20 | Astrazeneca Ab | New compounds |
| WO2008019395A2 (en) | 2006-08-10 | 2008-02-14 | Translational Genomics Research Institute | Compounds for improving learning and memory |
| US20080044390A1 (en) | 2006-08-11 | 2008-02-21 | Xiaowei Jin | Methods and compositions for the treatment of neurodegenerative disorders |
| CN101612157A (zh) | 2008-06-26 | 2009-12-30 | 天津红日药业股份有限公司 | 法舒地尔诱导成年脑内源性神经干细胞再生的用途 |
| US9980972B2 (en) | 2012-03-12 | 2018-05-29 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | Rho kinase inhibitors for use in treating familial amyotrophic lateral sclerosis |
| WO2015070170A1 (en) * | 2013-11-08 | 2015-05-14 | The Translational Genomics Research Institute | Compounds for cognitive enhancement and methods of use thereof |
| US10537567B2 (en) * | 2017-07-11 | 2020-01-21 | BioAxone BioSciences, Inc. | Kinase inhibitors for treatment of disease |
| WO2019018855A1 (en) * | 2017-07-21 | 2019-01-24 | Kadmon Corporation, Llc | ALPHA PROPELLER PROTEIN KINASE INHIBITORS ("COILED-COIL") ASSOCIATED WITH RHO |
| EP3868408A4 (en) | 2018-10-15 | 2022-07-06 | National University Corporation Tokai National Higher Education and Research System | Antipsychotic and use thereof |
| MX2022008513A (es) * | 2020-01-09 | 2022-08-08 | Woolsey Pharmaceuticals Inc | Metodos para tratar la deambulacion asociada con la demencia cortical. |
| US11642352B2 (en) | 2020-03-25 | 2023-05-09 | Woolsey Pharmaceuticals, Inc. | Methods of treating wandering in Lewy dody dementia |
| CA3169944A1 (en) | 2020-03-25 | 2021-09-30 | Thomas Macallister | Methods of using rho kinase inhibitors to treat frontotemporal dementia |
| WO2021216139A1 (en) * | 2020-04-23 | 2021-10-28 | Woolsey Pharmaceuticals, Inc | Methods of using rho kinase inhibitors to treat alzheimer's disease |
| CN116249532A (zh) | 2020-06-15 | 2023-06-09 | 乌尔塞制药公司 | 使用Rho激酶抑制剂治疗血管性痴呆的方法 |
| MX2022016336A (es) | 2020-06-25 | 2023-01-24 | Woolsey Pharmaceuticals Inc | Metodos de tratamiento de trastornos del neurodesarrollo. |
| MX2023000600A (es) | 2020-07-14 | 2023-02-13 | Woolsey Pharmaceuticals Inc | Metodos de tratamiento de proteinopatias. |
| EP4232041A4 (en) | 2020-10-22 | 2024-09-25 | Woolsey Pharmaceuticals, Inc. | Methods of treating 4-repeat tauopathies |
| US20220331333A1 (en) | 2021-04-16 | 2022-10-20 | Universite De Strasbourg | Rhoa pathway inhibitor in the treatment of neurodevelopmental disorder or neuropsychiatric disorder |
| WO2022245708A1 (en) | 2021-05-19 | 2022-11-24 | Woolsey Pharmaceuticals, Inc. | Methods of treating depression and anxiety |
| MX2023013538A (es) | 2021-05-19 | 2023-11-27 | Woolsey Pharmaceuticals Inc | Metodos para tratar la depresion y la ansiedad. |
-
2022
- 2022-11-15 US US18/712,654 patent/US20240423998A1/en active Pending
- 2022-11-15 CN CN202280078331.XA patent/CN118354769A/zh active Pending
- 2022-11-15 EP EP22899474.5A patent/EP4440566A4/en active Pending
- 2022-11-15 WO PCT/US2022/079861 patent/WO2023097151A1/en not_active Ceased
- 2022-11-15 JP JP2024526913A patent/JP2024544500A/ja active Pending
- 2022-11-15 CA CA3236462A patent/CA3236462A1/en active Pending
- 2022-11-15 MX MX2024006505A patent/MX2024006505A/es unknown
-
2023
- 2023-03-02 US US18/177,188 patent/US11865119B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Molinuevo et al. | Memantine: targeting glutamate excitotoxicity in Alzheimer's disease and other dementias | |
| JP2024544500A5 (https=) | ||
| US11318144B2 (en) | Compositions and methods for treating Alzheimer's disease and Parkinson's disease | |
| JP2021080276A (ja) | デクスメデトミジン製剤を使用する睡眠障害の予防または治療 | |
| KR101581611B1 (ko) | 정신, 행동, 인지 장애의 예방 및 치료용 약학적 조성물 | |
| JP2023518707A5 (https=) | ||
| JP2023058666A (ja) | アルツハイマー型認知症予防または治療剤 | |
| WO2021262196A1 (en) | Compositions and methods for treating alzheimer's disease and parkinson's disease | |
| JP2024503727A5 (https=) | ||
| CN1104241C (zh) | 1－(2－萘－2－基乙基)－4－(3－三氟甲基苯基)－1,2,3,6－四氢吡啶用于制备治疗肌萎缩性脊髓侧索硬化的药物的用途 | |
| Bajic et al. | Treatment of Alzheimer's disease: classical therapeutic approach | |
| JPWO2008090736A1 (ja) | アルツハイマー型認知症の予防及び治療のための医薬 | |
| CN107847504A (zh) | 淀粉状蛋白β的加兰他敏清除 | |
| TW470646B (en) | Pharmaceutical composition for use in the treatment of conditions requiring inhibition of vascular smooth muscle cell migration comprising R(+) isomer of amlodipine | |
| CN114040763A (zh) | 突触核蛋白病的治疗 | |
| CA3185939A1 (en) | N'-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl) ethynyl]-benzohydrazide for treatment of alzheimer's disease | |
| CN1921844A (zh) | 胆碱酯酶抑制剂治疗血管性抑郁症的用途 | |
| JPH0256420A (ja) | アスパラギン酸アルギニンを含む記憶障害治療薬 | |
| US20190350918A1 (en) | PPARy AGONIST FOR TREATMENT OF HUNTINGTON'S DISEASE | |
| JP2023554354A (ja) | アルツハイマー病の処置のためのマシチニブ | |
| JP2024543347A5 (https=) | ||
| JP2024518426A5 (https=) | ||
| JP2008501656A (ja) | β−アミロイド（Ａβ４０及びＡβ４２）生成阻害のためのモノアミン神経伝達物質再取り込み阻害剤 | |
| CN112437661A (zh) | 苯甲酸或其盐用于预防或治疗抗n-甲基-d-天冬氨酸受体脑炎的用途 | |
| TW396038B (en) | Pharmaceutical composition comprising felodipine for treating cerebral dysfunction due to solvent exposure |